Company Filing History:
Years Active: 2010
Title: **Emily Sheng-Ming Shen: Innovator in Bone Health Therapies**
Introduction
Emily Sheng-Ming Shen, based in West Chester, PA, is an accomplished inventor in the field of biomedical innovation. With a focus on treatments for bone disorders, he has made significant contributions to the field, evidenced by his two patents.
Latest Patents
Shen's latest patents include groundbreaking work on GDF-9/BMP-15 modulators for the treatment of bone disorders. This invention outlines methods to treat or prevent various bone degenerative disorders, such as osteopenia, osteoporosis, and Paget's disease. The methods involve administering a GDF-9 or BMP-15 inhibitor to mammals to not only treat these conditions but also to promote new bone formation and maintain bone quality. Another noteworthy patent pertains to Finger-1 peptide analogs of the TGF-β superfamily, which are used for purifying solutions and offering therapeutic applications.
Career Highlights
Emily Shen has built his career at Wyeth, a prominent company in the pharmaceutical industry. His work in developing inventive solutions for bone health has been crucial in addressing prevalent health concerns related to bone integrity and density.
Collaborations
Throughout his career, Shen has collaborated with esteemed colleagues such as Zhijian Lu and Wei Liu. Their teamwork has facilitated advancements in the development of innovative treatments, strengthening the potential impact on patient care.
Conclusion
Emily Sheng-Ming Shen stands out as a significant figure in the realm of biomedical inventions, specifically focusing on bone health. His contributions not only highlight his ingenuity but also pave the way for future innovations in treating bone disorders, making a lasting impact on the field of medicine.